Alice Laberge - Nutrien Independent Director
| NTR Stock | USD 58.86 0.35 0.59% |
Director
Ms. Alice D. Laberge serves as Director of the Company. Ms. Laberge is a Corporationrationrate Director and the former President and Chief Executive Officer of Fincentric Corporationrationration. She was previously Senior Vice President and Chief Financial Officer of MacMillan Bloedel Ltd. She is a director of the Royal Bank of Canada, Russel Metals Inc. and the B.C. Cancer Foundation and has served as a director of Delta Hotels Ltd. and Catalyst Paper Corporationrationration. Ms. Laberge is the past Chair of the Board of Governors of the University of British Columbia. She is a Fellow of the Institute of Corporationrationrate Directors. since 2018.
| Age | 63 |
| Tenure | 6 years |
| Address | 211 19th Street East, Saskatoon, SK, Canada, S7K 5R6 |
| Phone | 306-933-8500 |
| Web | https://www.nutrien.com |
Nutrien Management Efficiency
The company has Return on Asset of 0.0351 % which means that on every $100 spent on assets, it made $0.0351 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0346 %, implying that it generated $0.0346 on every 100 dollars invested. Nutrien's management efficiency ratios could be used to measure how well Nutrien manages its routine affairs as well as how well it operates its assets and liabilities. As of 05/25/2024, Return On Tangible Assets is likely to grow to 0.06, while Return On Capital Employed is likely to drop 0.09. At this time, Nutrien's Fixed Asset Turnover is relatively stable compared to the past year.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Carol Davidson | FMC Corporation | 65 | |
| Ruth Ralbag | ICL Israel Chemicals | 59 | |
| Jonathan Frates | CVR Partners LP | 37 | |
| Scott Baskin | American Vanguard | 66 | |
| John Eaves | CF Industries Holdings | 63 | |
| Reem Aminoach | ICL Israel Chemicals | 59 | |
| Peter Shea | CVR Partners LP | 68 | |
| Celso White | CF Industries Holdings | 59 | |
| William Kuser | American Vanguard | N/A | |
| David Evans | Scotts Miracle Gro | 61 | |
| KLynne Johnson | FMC Corporation | 52 | |
| Luciano Pires | The Mosaic | 50 | |
| Sagi Kabla | ICL Israel Chemicals | 44 | |
| Nancy Cooper | The Mosaic | 66 | |
| Brian Finn | Scotts Miracle Gro | 60 | |
| William Davisson | CF Industries Holdings | 72 | |
| Stephen Johnson | Scotts Miracle Gro | 69 | |
| Thomas Kelly | Scotts Miracle Gro | 73 | |
| Morton Erlich | American Vanguard | 75 | |
| Robert Arzbaecher | CF Industries Holdings | 61 | |
| Paul Norris | FMC Corporation | 73 | |
Management Performance
| Return On Equity | 0.0346 | ||||
| Return On Asset | 0.0351 |
Nutrien Leadership Team
Elected by the shareholders, the Nutrien's board of directors comprises two types of representatives: Nutrien inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nutrien. The board's role is to monitor Nutrien's management team and ensure that shareholders' interests are well served. Nutrien's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nutrien's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Susan Jones, Executive Vice President, Chief Executive Officer of Potash Nutrien | ||
| Consuelo Madere, Independent Director | ||
| Joseph Podwika, Executive Vice President Chief Legal Officer | ||
| Russell Girling, Independent Chairman of the Board | ||
| Robert Kirkpatrick, Interim Chief Legal Officer, Senior Vice President General Counsel, Securities, Corporate Secretary | ||
| Candace Laing, VP Officer | ||
| Christopher Reynolds, Executive Potash | ||
| Pedro Farah, Chief Financial Officer, Executive Vice President | ||
| Fred Thun, Senior Vice President - Finance | ||
| Michael Frank, Executive Vice President, Chief Executive Officer - Retail Nutrien | ||
| Kenneth Seitz, Executive Vice President, Chief Executive Officer - Potash | ||
| Jeffrey Tarsi, Executive Retail | ||
| Andrew Kelemen, Executive Officer | ||
| Charlotte Hebebrand, Executive Vice President Chief Sustainability Officer | ||
| Leslie ODonoghue, Executive Vice President Chief Strategy & Corporate Development Officer | ||
| Charles Magro, President, Chief Executive Officer, Director | ||
| John Estey, Independent Director | ||
| Megan Fielding, VP Communications | ||
| Robert QC, Corporate Secretary | ||
| Jeff Holzman, Vice Relations | ||
| Maura Clark, Independent Director | ||
| Christopher Burley, Independent Director | ||
| Michael Webb, Chief Human Resource Officer, Executive Vice President, Chief Administrative Officer | ||
| David Everitt, Independent Director | ||
| Raef Sully, Executive Vice President, v& Chief Executive Officer of Phosphate & Nitrogen | ||
| Jason Newton, Head Economist | ||
| Mayo Schmidt, President, Chief Executive Officer, Director | ||
| Keith Martell, Independent Director | ||
| Miranda Hubbs, Independent Director | ||
| Noralee LLB, Executive Officer | ||
| Noralee Bradley, Executive Vice President Chief Legal Officer | ||
| Andy Kelemen, Executive Officer | ||
| Brent Poohkay, Executive Vice President, Chief Information Officer | ||
| Trevor Williams, Executive Phosphate | ||
| Alice Laberge, Independent Director | ||
| Nelson Silva, Independent Director | ||
| Steven Douglas, Executive Vice President Chief Integration Officer | ||
| Aaron Regent, Independent Director | ||
| Mark Thompson, Executive Vice President Chief Corporate Development and Strategy Officer |
Nutrien Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nutrien a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0346 | ||||
| Return On Asset | 0.0351 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 42.3 B | ||||
| Shares Outstanding | 494.63 M | ||||
| Shares Owned By Insiders | 0.02 % | ||||
| Shares Owned By Institutions | 68.70 % | ||||
| Number Of Shares Shorted | 4.23 M | ||||
| Price To Earning | 75.49 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutrien. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Nutrien Stock, please use our How to Invest in Nutrien guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Nutrien Stock analysis
When running Nutrien's price analysis, check to measure Nutrien's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutrien is operating at the current time. Most of Nutrien's value examination focuses on studying past and present price action to predict the probability of Nutrien's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutrien's price. Additionally, you may evaluate how the addition of Nutrien to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Nutrien's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nutrien. If investors know Nutrien will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nutrien listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.72) | Dividend Share 2.13 | Earnings Share 1.71 | Revenue Per Share 55.232 | Quarterly Revenue Growth (0.13) |
The market value of Nutrien is measured differently than its book value, which is the value of Nutrien that is recorded on the company's balance sheet. Investors also form their own opinion of Nutrien's value that differs from its market value or its book value, called intrinsic value, which is Nutrien's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nutrien's market value can be influenced by many factors that don't directly affect Nutrien's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nutrien's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nutrien is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nutrien's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.